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Introduction
Many intravenous (IV) drugs are required for complex and
polypathologic critically ill ICU patients management. ICU
nurses are daily confronted with drugs preparation and
administration (solvent type and volume, infusion rate).
They also have to deal with drugs physiochemical incom-
patibilities (PCI), especially as various IV medications are
delivered via a single catheter lumen. PCI may induce a
loss of drug efficiency, catheter thrombosis and embolism.
Data about drugs PCI in ICU are scarce (1).
Objectives
To assess nurses’ knowledge about IV drugs administra-
tion and to evaluate drug incompatibilities before and
after a multifaceted intervention.
Methods
Prospective monocentric interventional study conducted
in a 18 bed ICU, divided in 2 phases.
Phase 1- survey of nursing practices by using:
a) semi-directive interviews targeting the whole nur-
sing staff according to general daily practice,
b) direct observation of all patients lines and mani-
folds by two independent observers twice a week for
3 weeks, in order to unveil drug incompatibilities.
Multifaceted intervention resulted in: computerized pre-
scription order entry (CPOE) update by nurses, pharmacists,
and physicians; online course for nurses and physicians;
posters; feedback and information to the entire ICU staff.
Phase 2: Post intervention evaluation using the same tools
as phase 1 (semi directive interviews and direct observations).
Results
48 nurses (98% of nurse’s team) reported their practices in
phase 1 and 2. 56 patients (121 observations, 1072 medica-
tions) vs 39 patients (120 observations, 1174 medications)
were observed during phase 1 and phase 2 respectively.
89% of the staff (nurses and physicians) attended the
online course. Medications involved in PCI showed differ-
ent pattern before (antibiotics, nicardipine, unfractioned
heparin) and after (sedatives /curares, parenteral nutrition,
unfractioned heparin) intervention. In phase 1, patients
had 2,7 IV lumen on average, and 3,2 in phase 2. PCI still
occurred despite preventive measures (at least one drug
PCI in 20% of the observation in phase 1 vs 22% in phase
2). Typology of patients, high nurses turnover, restricted
number for IV access may have been limiting factors.
Nevertheless, standardization of drugs preparation and
educational tool improved nurses’ knowledge and devel-
oped a real team awareness about drugs PCI.
Conclusion
Drug incompatibilities are common in ICU and mainly
occur with drugs used daily. ICU patient’s typology and
the high number of IV medications are limiting for strict
application of pharmaceutical recommendations. Mana-
ging incompatibilities of IV drugs for these patients is
challenging. Further study aiming to test the impact of
4 lumen catheters, (in association with a multifaceted
program), in reducing drug PCI is on going.
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